BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 78764)

  • 1. Observations on cell lines derived from a patient with Hodgkin's disease.
    Friend C; Marovitz W; Henie G; Henie W; Tsuei D; Hirschhorn K; Holland JG; Cuttner J
    Cancer Res; 1978 Aug; 38(8):2581-91. PubMed ID: 78764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultural, morphological, cell membrane, enzymatic, and neoplastic properties of cell lines derived from a Hodgkin's disease lymph node.
    Roberts AN; Smith KL; Dowell BL; Hubbard AK
    Cancer Res; 1978 Sep; 38(9):3033-43. PubMed ID: 209894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a cloned giant cell line from a patient with Hodgkin's disease.
    Olsson L; Behnke O; Pleibel N; D'Amore F; Werdelin O; Fry KE; Kaplan HS
    J Natl Cancer Inst; 1984 Oct; 73(4):809-30. PubMed ID: 6332936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
    Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
    Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
    Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
    Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of Ph1-positive and Ph1-negative lymphoblastoid cell lines from a patient with chronic myelogenous leukemia.
    Yamada T; Sasaki M; Yoshida MC; Aya T; Koizumi S; Osato T
    Jpn J Cancer Res; 1985 May; 76(5):365-73. PubMed ID: 2989064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines.
    Sundström C; Nilsson K
    Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):173-84. PubMed ID: 211794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Presence of human cytomegalovirus within the neoplastic cells of Hodgkin's disease].
    Huang GS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):403-5. PubMed ID: 12940088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications.
    Diehl V; Pfreundschuh M; Fonatsch C; Stein H; Falk M; Burrichter H; Schaadt M
    Cancer Surv; 1985; 4(2):399-419. PubMed ID: 3842319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease.
    Huang G; Yan Q; Wang Z; Chen X; Zhang X; Guo Y; Li JJ
    Int J Oncol; 2002 Jul; 21(1):31-6. PubMed ID: 12063546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.
    Faumont N; Trempat P; Brousset P; Delsol G; Meggetto F
    Virus Res; 2004 May; 101(2):163-73. PubMed ID: 15041184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Particles with retrovirus appearance and reverse transcriptase activity in cell cultures derived from lymph node biopsies in Hodgkin's disease].
    Lesser J; Dormont D; Tourani JM; Schwartz O; Fleury H; Neveux Y; Audroin C; Andrieu JM
    C R Acad Sci III; 1987; 305(8):295-300. PubMed ID: 2443226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease.
    Delecluse HJ; Marafioti T; Hummel M; Dallenbach F; Anagnostopoulos I; Stein H
    J Pathol; 1997 Aug; 182(4):475-9. PubMed ID: 9306970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.